An NK cell line (NK92-41BB) expressing high levels of granzyme is engineered to express the high affinity chimeric genes CD16/CAR View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-07-12

AUTHORS

Hui Zhao, Zhenlong Zhou, Guangmeng Li, Gang Liu, Shuyin Lin, Wei Chen, Sheng Xiong

ABSTRACT

Natural killer (NK) cells are known to play a role in mediating innate immunity and have been implicated in mediating anti-tumor responses via antibody-dependent cell-mediated cytotoxicity (ADCC) based on the reactivity of CD16 with the Fc region of human IgG1 antibodies. The NK-92 cell line, devoid of CD16 and derived from a lymphoma patient, has been well characterized. The adoptive transfer of irradiated NK-92 cells demonstrated safety and showed preliminary evidence of clinical benefit for cancer patients. The molecules 41BB and CD3 are commonly used as stimulators in the CAR structure, and their expression in NK cells can promote the activation of NK cells, leading to the enhanced perforin- and granzyme-mediated lysis of tumor cells. This study showed that genetically modified NK-92 cells combined with antibody-mediated ADCC using rituximab and trastuzumab monoclonal antibodies lysed tumor cells more efficient than the NK-92 cell lines. It also showed that the anti-tumor activity of chimeric stimulator molecules of the CAR-modified CD16 receptor was stronger than that of CD16 (allotype V158). These studies provide a rationale for the use of genetically modified NK-92 cells in combination with IgG1 anti-tumor monoclonal antibodies. We also provide a rationale for the chimeric modified CD16 receptor that can improve the anti-tumor effect of NK92 cells via ADCC. More... »

PAGES

539-553

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10616-021-00476-1

DOI

http://dx.doi.org/10.1007/s10616-021-00476-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1139632098

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34349345


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.258164.c", 
          "name": [
            "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhao", 
        "givenName": "Hui", 
        "id": "sg:person.010702541313.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010702541313.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.258164.c", 
          "name": [
            "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Zhenlong", 
        "id": "sg:person.011407432125.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011407432125.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, 511436, Guangzhou, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.410737.6", 
          "name": [
            "Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, 511436, Guangzhou, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Guangmeng", 
        "id": "sg:person.012422006377.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012422006377.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.258164.c", 
          "name": [
            "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Gang", 
        "id": "sg:person.0713670073.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713670073.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.258164.c", 
          "name": [
            "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lin", 
        "givenName": "Shuyin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.258164.c", 
          "name": [
            "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Wei", 
        "id": "sg:person.01112200601.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112200601.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Guangdong Province Engineering Research Center for Antibody Drug and Immunoassay, Jinan University, 510632, Guangzhou, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.258164.c", 
          "name": [
            "Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People\u2019s Republic of China", 
            "Guangdong Province Engineering Research Center for Antibody Drug and Immunoassay, Jinan University, 510632, Guangzhou, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xiong", 
        "givenName": "Sheng", 
        "id": "sg:person.01372510344.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372510344.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s13045-017-0437-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084251894", 
          "https://doi.org/10.1186/s13045-017-0437-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/cgt.2011.66", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042612902", 
          "https://doi.org/10.1038/cgt.2011.66"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-07-12", 
    "datePublishedReg": "2021-07-12", 
    "description": "Natural killer (NK) cells are known to play a role in mediating innate immunity and have been implicated in mediating anti-tumor responses via antibody-dependent cell-mediated cytotoxicity (ADCC) based on the reactivity of CD16 with the Fc region of human IgG1 antibodies. The NK-92 cell line, devoid of CD16 and derived from a lymphoma patient, has been well characterized. The adoptive transfer of irradiated NK-92 cells demonstrated safety and showed preliminary evidence of clinical benefit for cancer patients. The molecules 41BB and CD3 are commonly used as stimulators in the CAR structure, and their expression in NK cells can promote the activation of NK cells, leading to the enhanced perforin- and granzyme-mediated lysis of tumor cells. This study showed that genetically modified NK-92 cells combined with antibody-mediated ADCC using rituximab and trastuzumab monoclonal antibodies lysed tumor cells more efficient than the NK-92 cell lines. It also showed that the anti-tumor activity of chimeric stimulator molecules of the CAR-modified CD16 receptor was stronger than that of CD16 (allotype V158). These studies provide a rationale for the use of genetically modified NK-92 cells in combination with IgG1 anti-tumor monoclonal antibodies. We also provide a rationale for the chimeric modified CD16 receptor that can improve the anti-tumor effect of NK92 cells via ADCC.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10616-021-00476-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1086307", 
        "issn": [
          "1381-5741", 
          "1573-0603"
        ], 
        "name": "Cytotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "73"
      }
    ], 
    "keywords": [
      "antibody-dependent cell-mediated cytotoxicity", 
      "NK-92 cells", 
      "NK-92 cell line", 
      "NK cells", 
      "CD16 receptor", 
      "tumor cells", 
      "anti-tumor monoclonal antibodies", 
      "cell lines", 
      "monoclonal antibodies", 
      "natural killer cells", 
      "anti-tumor response", 
      "cell-mediated cytotoxicity", 
      "NK cell line", 
      "anti-tumor effects", 
      "anti-tumor activity", 
      "adoptive transfer", 
      "killer cells", 
      "human IgG1 antibody", 
      "lymphoma patients", 
      "clinical benefit", 
      "cancer patients", 
      "NK92 cells", 
      "IgG1 antibodies", 
      "innate immunity", 
      "CD16", 
      "antibodies", 
      "patients", 
      "preliminary evidence", 
      "Fc region", 
      "receptors", 
      "cells", 
      "high levels", 
      "CD3", 
      "perforin", 
      "granzyme", 
      "immunity", 
      "rationale", 
      "stimulator", 
      "trastuzumab monoclonal antibody", 
      "study", 
      "cytotoxicity", 
      "activation", 
      "lysis", 
      "safety", 
      "chimeric", 
      "expression", 
      "lines", 
      "response", 
      "evidence", 
      "levels", 
      "activity", 
      "role", 
      "benefits", 
      "effect", 
      "reactivity", 
      "car structure", 
      "use", 
      "combination", 
      "molecules", 
      "region", 
      "transfer", 
      "car", 
      "structure", 
      "reactivity of CD16", 
      "molecules 41BB", 
      "granzyme-mediated lysis", 
      "antibody-mediated ADCC", 
      "chimeric stimulator molecules", 
      "stimulator molecules", 
      "IgG1 anti-tumor monoclonal antibodies", 
      "high affinity chimeric genes CD16/CAR", 
      "affinity chimeric genes CD16/CAR", 
      "chimeric genes CD16/CAR", 
      "genes CD16/CAR", 
      "CD16/CAR"
    ], 
    "name": "An NK cell line (NK92-41BB) expressing high levels of granzyme is engineered to express the high affinity chimeric genes CD16/CAR", 
    "pagination": "539-553", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1139632098"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10616-021-00476-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34349345"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10616-021-00476-1", 
      "https://app.dimensions.ai/details/publication/pub.1139632098"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_900.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10616-021-00476-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00476-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00476-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00476-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00476-1'


 

This table displays all metadata directly associated to this object as RDF triples.

191 TRIPLES      22 PREDICATES      103 URIs      93 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10616-021-00476-1 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author Nc3b692704c9640349ee870f17a409f01
4 schema:citation sg:pub.10.1038/cgt.2011.66
5 sg:pub.10.1186/s13045-017-0437-8
6 schema:datePublished 2021-07-12
7 schema:datePublishedReg 2021-07-12
8 schema:description Natural killer (NK) cells are known to play a role in mediating innate immunity and have been implicated in mediating anti-tumor responses via antibody-dependent cell-mediated cytotoxicity (ADCC) based on the reactivity of CD16 with the Fc region of human IgG1 antibodies. The NK-92 cell line, devoid of CD16 and derived from a lymphoma patient, has been well characterized. The adoptive transfer of irradiated NK-92 cells demonstrated safety and showed preliminary evidence of clinical benefit for cancer patients. The molecules 41BB and CD3 are commonly used as stimulators in the CAR structure, and their expression in NK cells can promote the activation of NK cells, leading to the enhanced perforin- and granzyme-mediated lysis of tumor cells. This study showed that genetically modified NK-92 cells combined with antibody-mediated ADCC using rituximab and trastuzumab monoclonal antibodies lysed tumor cells more efficient than the NK-92 cell lines. It also showed that the anti-tumor activity of chimeric stimulator molecules of the CAR-modified CD16 receptor was stronger than that of CD16 (allotype V158). These studies provide a rationale for the use of genetically modified NK-92 cells in combination with IgG1 anti-tumor monoclonal antibodies. We also provide a rationale for the chimeric modified CD16 receptor that can improve the anti-tumor effect of NK92 cells via ADCC.
9 schema:genre article
10 schema:inLanguage en
11 schema:isAccessibleForFree false
12 schema:isPartOf Nb2f173c215b54a298de3fd6984afd674
13 Nb5e7e5e7373f4282b4cf656d425e2473
14 sg:journal.1086307
15 schema:keywords CD16
16 CD16 receptor
17 CD16/CAR
18 CD3
19 Fc region
20 IgG1 anti-tumor monoclonal antibodies
21 IgG1 antibodies
22 NK cell line
23 NK cells
24 NK-92 cell line
25 NK-92 cells
26 NK92 cells
27 activation
28 activity
29 adoptive transfer
30 affinity chimeric genes CD16/CAR
31 anti-tumor activity
32 anti-tumor effects
33 anti-tumor monoclonal antibodies
34 anti-tumor response
35 antibodies
36 antibody-dependent cell-mediated cytotoxicity
37 antibody-mediated ADCC
38 benefits
39 cancer patients
40 car
41 car structure
42 cell lines
43 cell-mediated cytotoxicity
44 cells
45 chimeric
46 chimeric genes CD16/CAR
47 chimeric stimulator molecules
48 clinical benefit
49 combination
50 cytotoxicity
51 effect
52 evidence
53 expression
54 genes CD16/CAR
55 granzyme
56 granzyme-mediated lysis
57 high affinity chimeric genes CD16/CAR
58 high levels
59 human IgG1 antibody
60 immunity
61 innate immunity
62 killer cells
63 levels
64 lines
65 lymphoma patients
66 lysis
67 molecules
68 molecules 41BB
69 monoclonal antibodies
70 natural killer cells
71 patients
72 perforin
73 preliminary evidence
74 rationale
75 reactivity
76 reactivity of CD16
77 receptors
78 region
79 response
80 role
81 safety
82 stimulator
83 stimulator molecules
84 structure
85 study
86 transfer
87 trastuzumab monoclonal antibody
88 tumor cells
89 use
90 schema:name An NK cell line (NK92-41BB) expressing high levels of granzyme is engineered to express the high affinity chimeric genes CD16/CAR
91 schema:pagination 539-553
92 schema:productId N27df193562824b709e891f5394ca04aa
93 Na2aa382dcccf4becb6a2228e90457610
94 Nab520da25fd749c19e0a519c73311a6e
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1139632098
96 https://doi.org/10.1007/s10616-021-00476-1
97 schema:sdDatePublished 2022-01-01T18:58
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N375ab879a5c545d4b049364b39283121
100 schema:url https://doi.org/10.1007/s10616-021-00476-1
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N1e09008d6cc241c8bdbc9da7bcaf17fd rdf:first sg:person.011407432125.95
105 rdf:rest Nd8a456120c8f47dd8a2926c27129a61c
106 N27df193562824b709e891f5394ca04aa schema:name doi
107 schema:value 10.1007/s10616-021-00476-1
108 rdf:type schema:PropertyValue
109 N35c8ac3c2b854545aee42e5f2f972968 rdf:first sg:person.0713670073.30
110 rdf:rest N969da04c95ab4a01b0a3cc539a37f5c5
111 N375ab879a5c545d4b049364b39283121 schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N395a0d5ea73348d5b62a0db619332ac6 rdf:first sg:person.01372510344.29
114 rdf:rest rdf:nil
115 N7fca7565b0424242a38cb7cc855e4873 schema:affiliation grid-institutes:grid.258164.c
116 schema:familyName Lin
117 schema:givenName Shuyin
118 rdf:type schema:Person
119 N9410049aa1c74a4aa4b85f49e9d84181 rdf:first sg:person.01112200601.62
120 rdf:rest N395a0d5ea73348d5b62a0db619332ac6
121 N969da04c95ab4a01b0a3cc539a37f5c5 rdf:first N7fca7565b0424242a38cb7cc855e4873
122 rdf:rest N9410049aa1c74a4aa4b85f49e9d84181
123 Na2aa382dcccf4becb6a2228e90457610 schema:name dimensions_id
124 schema:value pub.1139632098
125 rdf:type schema:PropertyValue
126 Nab520da25fd749c19e0a519c73311a6e schema:name pubmed_id
127 schema:value 34349345
128 rdf:type schema:PropertyValue
129 Nb2f173c215b54a298de3fd6984afd674 schema:issueNumber 4
130 rdf:type schema:PublicationIssue
131 Nb5e7e5e7373f4282b4cf656d425e2473 schema:volumeNumber 73
132 rdf:type schema:PublicationVolume
133 Nc3b692704c9640349ee870f17a409f01 rdf:first sg:person.010702541313.66
134 rdf:rest N1e09008d6cc241c8bdbc9da7bcaf17fd
135 Nd8a456120c8f47dd8a2926c27129a61c rdf:first sg:person.012422006377.75
136 rdf:rest N35c8ac3c2b854545aee42e5f2f972968
137 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
138 schema:name Medical and Health Sciences
139 rdf:type schema:DefinedTerm
140 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
141 schema:name Immunology
142 rdf:type schema:DefinedTerm
143 sg:journal.1086307 schema:issn 1381-5741
144 1573-0603
145 schema:name Cytotechnology
146 schema:publisher Springer Nature
147 rdf:type schema:Periodical
148 sg:person.010702541313.66 schema:affiliation grid-institutes:grid.258164.c
149 schema:familyName Zhao
150 schema:givenName Hui
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010702541313.66
152 rdf:type schema:Person
153 sg:person.01112200601.62 schema:affiliation grid-institutes:grid.258164.c
154 schema:familyName Chen
155 schema:givenName Wei
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112200601.62
157 rdf:type schema:Person
158 sg:person.011407432125.95 schema:affiliation grid-institutes:grid.258164.c
159 schema:familyName Zhou
160 schema:givenName Zhenlong
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011407432125.95
162 rdf:type schema:Person
163 sg:person.012422006377.75 schema:affiliation grid-institutes:grid.410737.6
164 schema:familyName Li
165 schema:givenName Guangmeng
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012422006377.75
167 rdf:type schema:Person
168 sg:person.01372510344.29 schema:affiliation grid-institutes:grid.258164.c
169 schema:familyName Xiong
170 schema:givenName Sheng
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372510344.29
172 rdf:type schema:Person
173 sg:person.0713670073.30 schema:affiliation grid-institutes:grid.258164.c
174 schema:familyName Liu
175 schema:givenName Gang
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713670073.30
177 rdf:type schema:Person
178 sg:pub.10.1038/cgt.2011.66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042612902
179 https://doi.org/10.1038/cgt.2011.66
180 rdf:type schema:CreativeWork
181 sg:pub.10.1186/s13045-017-0437-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084251894
182 https://doi.org/10.1186/s13045-017-0437-8
183 rdf:type schema:CreativeWork
184 grid-institutes:grid.258164.c schema:alternateName Guangdong Province Engineering Research Center for Antibody Drug and Immunoassay, Jinan University, 510632, Guangzhou, People’s Republic of China
185 Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People’s Republic of China
186 schema:name Guangdong Province Engineering Research Center for Antibody Drug and Immunoassay, Jinan University, 510632, Guangzhou, People’s Republic of China
187 Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, 510632, Guangzhou, People’s Republic of China
188 rdf:type schema:Organization
189 grid-institutes:grid.410737.6 schema:alternateName Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, 511436, Guangzhou, People’s Republic of China
190 schema:name Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, 511436, Guangzhou, People’s Republic of China
191 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...